Treatment of congenital hypofunction of metabolism,
Prevent and treat vitamin B6 deficiency.
Treatment of congenital hypofunction of metabolism,Prevent and treat vitamin B6 deficiency.
Items of Test | BP2008 | USP32 |
Appearance
| Yellow or orange-yellow crystalline powder | |
Identification | Pass A.B.C&D tests
| Pass A&B tests
|
Lumiflavin
| 440nm NMT BY6
| 440nm NMT 0.025
|
Related Substances
| Free Riboflavin: ≤6.0% Riboflavin Diphosphate: ≤6.0%
| Free Riboflavin: ≤6.0% Riboflavin Diphosphate: ≤6.0%
|
Free Phosphate
| ≤1.5%
| ≤1.0%
|
Heavy Metals
| <10ppm
|
|
OrganicVolatileImpurities |
| Meets the requirements |
Residue on Ignition
|
| 21.1%
|
Acidity / PH Value
| 6.0
| 6.0
|
Specific Rotation
| +39.8º
| +39.3º
|
Loss on Drying
| 5.3%
| 5.3%
|
Assay(on dried basis)
| 76.8%
| 74.8% |
Pyridoxine hydrochloride | ||
Identification | ||
Name |
| Pyridoxine hydrochloride |
Synonyms |
| 5-Hydroxy-6-methyl-3,4-pyridinedimethanol; 2-Methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine hydrochloride; 3-Hydroxy-4,5-dimethylol-a-picoline hydrochloride; Pyridoxol hydrochloride; Pyridoxyl hydrochloride; Adermin hydrochloride; Vitamin B6 |
Molecular Formula |
| C8H11NO3.HCl;C8H12ClNO3 |
Molecular Weight |
| 205.64 |
CAS Registry Number |
| 58-56-0 |
EINECS |
| 200-386-2 |
Properties | ||
Melting point |
| 214 ºC |
Water solubility |
| 0.1 g/mL (20 ºC) |
Safety Data | ||
Hazard Symbols |
| Xi |
Risk Codes |
| R36/37/38 |
Safety Description |
| S26;S37/39 |
